OpGen, Inc.
OPGN
$1.15
-$0.53-31.55%
| Weiss Ratings | OPGN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | OPGN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | OPGN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -0.44 | |||
| Price History | OPGN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 57.53% | |||
| 30-Day Total Return | 5.58% | |||
| 60-Day Total Return | 3.60% | |||
| 90-Day Total Return | -31.14% | |||
| Year to Date Total Return | 116.98% | |||
| 1-Year Total Return | -76.75% | |||
| 2-Year Total Return | -91.48% | |||
| 3-Year Total Return | -99.31% | |||
| 5-Year Total Return | -99.86% | |||
| 52-Week High % Change | -83.03% | |||
| 52-Week Low % Change | 218.60% | |||
| Price | OPGN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $9.90 | |||
| 52-Week Low Price | $0.53 | |||
| 52-Week Low Price (Date) | Jan 02, 2025 | |||
| 52-Week High Price (Date) | Mar 26, 2024 | |||
| Valuation | OPGN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 16.91M | |||
| Enterprise Value | 17.34M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -14.10 | |||
| Earnings Per Share Growth | -78.39% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 8.77 | |||
| Price/Book (Q) | 5.66 | |||
| Enterprise Value/Revenue (TTM) | 13.70 | |||
| Price | $1.15 | |||
| Enterprise Value/EBITDA (TTM) | -3.10 | |||
| Enterprise Value/EBIT | -2.90 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | OPGN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 6.60M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | OPGN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 240 813 1260 | |||
| Address | 9717 Key West Avenue Rockville, MD 20850 | |||
| Website | www.opgen.com | |||
| Country | United States | |||
| Year Founded | 2001 | |||
| Profitability | OPGN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -471.86% | |||
| Profit Margin | -742.51% | |||
| Management Effectiveness | OPGN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -31.63% | |||
| Return on Equity | -- | |||
| Income Statement | OPGN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 1.27M | |||
| Total Revenue (TTM) | 1.27M | |||
| Revenue Per Share | $0.19 | |||
| Gross Profit (TTM) | -323.90K | |||
| EBITDA (TTM) | -5.60M | |||
| EBIT (TTM) | -5.97M | |||
| Net Income (TTM) | -9.40M | |||
| Net Income Avl. to Common (TTM) | -9.40M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 319.82% | |||
| EPS Diluted (TTM) | -14.10 | |||
| EPS Diluted Growth (Q YOY) | 129.16% | |||
| Balance Sheet | OPGN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 1.63M | |||
| Cash Per Share (Q) | $0.25 | |||
| Total Current Assets (Q) | 3.22M | |||
| Total Preferred Equity (Q) | 0.00 | |||
| Total Equity (Q) | 2.99M | |||
| Current Ratio (Q) | 5.455 | |||
| Book Value Per Share (Q) | $0.30 | |||
| Total Assets (Q) | 5.47M | |||
| Total Current Liabilities (Q) | 589.80K | |||
| Total Debt (Q) | 2.06M | |||
| Total Liabilities (Q) | 2.48M | |||
| Total Common Equity (Q) | 2.99M | |||
| Cash Flow | OPGN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -900.00 | |||
| Cash from Financing (TTM) | 7.22M | |||
| Net Change in Cash (TTM) | 1.15M | |||
| Levered Free Cash Flow (TTM) | -3.82M | |||
| Cash from Operations (TTM) | -6.31M | |||
